WHO ICTRP trial
Safety and efficacy of tick-borne encephalitis vaccine
JPRN-UMIN000035862 · Japan Primary Registries Network (JPRN) · Recruiting
Key facts
| Trial ID | JPRN-UMIN000035862 |
|---|---|
| Public title | Safety and efficacy of tick-borne encephalitis vaccine |
| Scientific title | Safety and efficacy of tick-borne encephalitis vaccine - TBEV2018 |
| Primary sponsor | Sapporo City General Hospital |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Phase II,III |
| Countries | Japan |
| Conditions | Tick-borne encephalitis |
| Interventions | Tick-borne encephalitis vaccine For 16 years and older FSME-IMMUN 0.5ml IM 3 vaccination(give 2nd 1 to 3 months after 1st, give 3rd 5 to 12 months after 2nd) For less than 16 years FSME-IMMUN Junior 0.25ml IM 3 vaccination(give 2nd 1 to 3… |
| Registration date | Dec 2, 2019 |
| Target size | 300 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: